MWG Caph Ltd

Est. AUM

$72.4M

13F long equity, this entity only

Positions

Period

Dec 2025 (Q4)

SEC EDGAR

Dec 2025 (Q4)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	BEAM THERAPEUTICS INC	COM	$35.1M	1266934	48.53%	DFND
2	LYELL IMMUNOPHARMA INC	COM NEW	$31.0M	1008116	42.88%	DFND
3	PRIME MEDICINE INC	COM	$6.2M	1792210	8.59%	DFND

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.